Skip to main content

Can a drug against diarrhoea be used to treat pulmonary hypertension?

Professor Raymond J MacAllister (lead researcher)

University College London

Start date: 01 October 2014 (Duration 2 years)

Clinical evaluation of a novel combination therapy for pulmonary hypertension

Pulmonary hypertension is a rare but serious condition in which high blood pressure in the arteries of the lungs results in narrowing of these blood vessels. Patients can have a poor quality of life and are at risk of developing heart failure because the heart has to work hard to pump against the high blood pressure in the lungs. Sildenafil (Viagra) is a medicine that helps reduce blood vessel narrowing in the lungs by relaxing the vessels, but the effect on the lungs may only be small. This London research team is testing a new treatment for pulmonary hypertension. They will give a small group of patients a medicine called racecadotril in addition to the standard treatment of sildenafil. Racecadotril, traditionally a treatment for diarrhoea, prevents the breakdown of a hormone called natriuretic peptide - lowering blood pressure in the lungs. Harnessing the body’s natural blood pressure controls could be a better way to treat this serious condition.

Project details

Grant amount £68,712
Grant type Project Grants
Application type Project Grant
Start Date 01 October 2014
Duration 2 years
Reference PG/11/88/28992
Status Complete
How much would you like to give?
Donate
Payment methods
How much would you like to give?
Donate monthly
Direct Debit Logo